Medicine and Dentistry
Myelodysplastic Syndrome
100%
Acute Myeloid Leukemia
42%
Diseases
29%
Reduced Intensity Conditioning
26%
Overall Survival
25%
Allogeneic Stem Cell Transplantation
25%
Hematopoietic Cell
23%
Hematopoietic Stem Cell Transplantation
20%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Graft Versus Host Reaction
19%
Aplastic Anemia
18%
Alemtuzumab
18%
Leukemia
16%
Leukemia Cell
15%
Programmed Cell Death
13%
Allograft
13%
Secondary Acute Myeloid Leukemia
11%
Myeloid Leukemia
11%
Conditioning
11%
Stem Cell
9%
Hazard Ratio
9%
Acute Leukemia
9%
International Prognostic Scoring System
8%
T Cell
8%
Hematologic Malignancy
8%
Disease Exacerbation
8%
Neoplasm
8%
Donor Lymphocyte Infusion
8%
Stem Cell Therapy
8%
Azacitidine
8%
Cytopenia
7%
Clinical Significance
7%
Liver Transplantation
7%
Chronic Myelogenous Leukemia
7%
Immunosuppressive Treatment
7%
Cancer
7%
Bone Marrow Failure
7%
Immunotherapy
6%
Cumulative Incidence
6%
Cell Transplantation
6%
DNA Damage
6%
Multivariate Analysis
6%
Thymocyte Antibody
6%
Fludarabine
6%
Chimeric Antigen Receptor T-Cell
6%
Long Term Survival
6%
Engraftment
6%
Pancytopenia
5%
Stem Cell Transplant
5%
Protein P53
5%
Immunology and Microbiology
Myeloid
66%
Conditioning
55%
Alemtuzumab
38%
Overall Survival
33%
Aplastic Anemia
32%
Allogeneic Stem Cell Transplantation
29%
Allogeneic Hematopoietic Stem Cell Transplantation
29%
Graft-Versus-Host Disease
26%
Hematopoietic Cell
24%
T Cell
21%
Hematopoietic Stem Cell Transplantation
18%
Regulatory T Cell
18%
Leukemia Cell
16%
T-Helper Cell
13%
Allograft
12%
Engraftment
11%
Stem Cell Transplantation
10%
Anti-Thymocyte Globulin
10%
Stem Cell
10%
Lymphocyte
10%
Programmed Cell Death
9%
Interleukin 2
9%
Chronic Graft Versus Host Disease
8%
Stem Cell Transplant
7%
Cell Transplantation
7%
Disease Free Survival
7%
Human Leukocyte Antigen
7%
CD38
6%
CD4
6%
Recurrence Free Survival
6%
Immunosuppressive Therapy
6%
CD80
5%
Immunotherapy
5%
Comorbidity
5%
CD3 Antigen
5%
Peptides
5%
Biochemistry, Genetics and Molecular Biology
Myeloid
40%
Cytogenetics
18%
T Cell
17%
Genomics
15%
Hematopoietic Cell
12%
Single-Nucleotide Polymorphism
10%
Allogeneic Stem Cell Transplantation
9%
DNA Damage
8%
Hematopoiesis
7%
Karyotype
7%
Non-Homologous End Joining
6%
Genetics
6%
Programmed Cell Death
6%
Karyotyping
6%
P53
6%
Genome Instability
6%
Overall Survival
5%
Conditioning
5%
Stem Cell
5%
Uniparental Disomy
5%